Oral Proteins And Peptides Market Size, Share & Trends Analysis Report By Drug Type (Linaclotide, Plecanatide, Calcitonin, Insulin, Octreotide, Others), By Molecule Type (Proteins, Peptides), By Application (Gastric and Digestive Disorders, Bone Diseases, Diabetes, Hormonal Disorders, Cancer, Others), By End-User (Hospitals, Clinics, Homecare Settings, Research Institutes, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Mitiksha Koul | Format:

Table Of Content

  1. Executive Summary

  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Oral Proteins And Peptides Market Size Analysis
    1. Introduction
    2. Oral Proteins And Peptides Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
      1. Linaclotide
      2. Plecanatide
      3. Calcitonin
      4. Insulin
      5. Octreotide
      6. Others
    3. Oral Proteins And Peptides Market Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
      1. Proteins
      2. Peptides
    4. Oral Proteins And Peptides Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Gastric and Digestive Disorders
      2. Bone Diseases
      3. Diabetes
      4. Hormonal Disorders
      5. Cancer
      6. Others
    5. Oral Proteins And Peptides Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Clinics
      3. Homecare Settings
      4. Research Institutes
      5. Others
  7. North America Oral Proteins And Peptides Market Size Analysis
    1. Introduction
    2. Oral Proteins And Peptides Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
      1. Linaclotide
      2. Plecanatide
      3. Calcitonin
      4. Insulin
      5. Octreotide
      6. Others
    3. Oral Proteins And Peptides Market Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
      1. Proteins
      2. Peptides
    4. Oral Proteins And Peptides Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Gastric and Digestive Disorders
      2. Bone Diseases
      3. Diabetes
      4. Hormonal Disorders
      5. Cancer
      6. Others
    5. Oral Proteins And Peptides Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Clinics
      3. Homecare Settings
      4. Research Institutes
      5. Others
    6. U.S.
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Proteins
        2. Peptides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gastric and Digestive Disorders
        2. Bone Diseases
        3. Diabetes
        4. Hormonal Disorders
        5. Cancer
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Homecare Settings
        4. Research Institutes
        5. Others
    7. Canada
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Proteins
        2. Peptides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gastric and Digestive Disorders
        2. Bone Diseases
        3. Diabetes
        4. Hormonal Disorders
        5. Cancer
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Homecare Settings
        4. Research Institutes
        5. Others
  8. Europe Oral Proteins And Peptides Market Size Analysis
    1. Introduction
    2. Oral Proteins And Peptides Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
      1. Linaclotide
      2. Plecanatide
      3. Calcitonin
      4. Insulin
      5. Octreotide
      6. Others
    3. Oral Proteins And Peptides Market Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
      1. Proteins
      2. Peptides
    4. Oral Proteins And Peptides Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Gastric and Digestive Disorders
      2. Bone Diseases
      3. Diabetes
      4. Hormonal Disorders
      5. Cancer
      6. Others
    5. Oral Proteins And Peptides Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Clinics
      3. Homecare Settings
      4. Research Institutes
      5. Others
    6. U.K.
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Proteins
        2. Peptides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gastric and Digestive Disorders
        2. Bone Diseases
        3. Diabetes
        4. Hormonal Disorders
        5. Cancer
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Homecare Settings
        4. Research Institutes
        5. Others
    7. Germany
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Proteins
        2. Peptides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gastric and Digestive Disorders
        2. Bone Diseases
        3. Diabetes
        4. Hormonal Disorders
        5. Cancer
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Homecare Settings
        4. Research Institutes
        5. Others
    8. France
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Proteins
        2. Peptides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gastric and Digestive Disorders
        2. Bone Diseases
        3. Diabetes
        4. Hormonal Disorders
        5. Cancer
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Homecare Settings
        4. Research Institutes
        5. Others
    9. Spain
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Proteins
        2. Peptides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gastric and Digestive Disorders
        2. Bone Diseases
        3. Diabetes
        4. Hormonal Disorders
        5. Cancer
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Homecare Settings
        4. Research Institutes
        5. Others
    10. Italy
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Proteins
        2. Peptides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gastric and Digestive Disorders
        2. Bone Diseases
        3. Diabetes
        4. Hormonal Disorders
        5. Cancer
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Homecare Settings
        4. Research Institutes
        5. Others
    11. Russia
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Proteins
        2. Peptides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gastric and Digestive Disorders
        2. Bone Diseases
        3. Diabetes
        4. Hormonal Disorders
        5. Cancer
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Homecare Settings
        4. Research Institutes
        5. Others
    12. Nordic
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Proteins
        2. Peptides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gastric and Digestive Disorders
        2. Bone Diseases
        3. Diabetes
        4. Hormonal Disorders
        5. Cancer
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Homecare Settings
        4. Research Institutes
        5. Others
    13. Benelux
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Proteins
        2. Peptides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gastric and Digestive Disorders
        2. Bone Diseases
        3. Diabetes
        4. Hormonal Disorders
        5. Cancer
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Homecare Settings
        4. Research Institutes
        5. Others
    14. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Proteins
        2. Peptides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gastric and Digestive Disorders
        2. Bone Diseases
        3. Diabetes
        4. Hormonal Disorders
        5. Cancer
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Homecare Settings
        4. Research Institutes
        5. Others
  9. APAC Oral Proteins And Peptides Market Size Analysis
    1. Introduction
    2. Oral Proteins And Peptides Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
      1. Linaclotide
      2. Plecanatide
      3. Calcitonin
      4. Insulin
      5. Octreotide
      6. Others
    3. Oral Proteins And Peptides Market Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
      1. Proteins
      2. Peptides
    4. Oral Proteins And Peptides Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Gastric and Digestive Disorders
      2. Bone Diseases
      3. Diabetes
      4. Hormonal Disorders
      5. Cancer
      6. Others
    5. Oral Proteins And Peptides Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Clinics
      3. Homecare Settings
      4. Research Institutes
      5. Others
    6. China
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Proteins
        2. Peptides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gastric and Digestive Disorders
        2. Bone Diseases
        3. Diabetes
        4. Hormonal Disorders
        5. Cancer
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Homecare Settings
        4. Research Institutes
        5. Others
    7. Korea
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Proteins
        2. Peptides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gastric and Digestive Disorders
        2. Bone Diseases
        3. Diabetes
        4. Hormonal Disorders
        5. Cancer
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Homecare Settings
        4. Research Institutes
        5. Others
    8. Japan
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Proteins
        2. Peptides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gastric and Digestive Disorders
        2. Bone Diseases
        3. Diabetes
        4. Hormonal Disorders
        5. Cancer
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Homecare Settings
        4. Research Institutes
        5. Others
    9. India
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Proteins
        2. Peptides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gastric and Digestive Disorders
        2. Bone Diseases
        3. Diabetes
        4. Hormonal Disorders
        5. Cancer
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Homecare Settings
        4. Research Institutes
        5. Others
    10. Australia
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Proteins
        2. Peptides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gastric and Digestive Disorders
        2. Bone Diseases
        3. Diabetes
        4. Hormonal Disorders
        5. Cancer
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Homecare Settings
        4. Research Institutes
        5. Others
    11. Taiwan
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Proteins
        2. Peptides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gastric and Digestive Disorders
        2. Bone Diseases
        3. Diabetes
        4. Hormonal Disorders
        5. Cancer
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Homecare Settings
        4. Research Institutes
        5. Others
    12. South East Asia
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Proteins
        2. Peptides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gastric and Digestive Disorders
        2. Bone Diseases
        3. Diabetes
        4. Hormonal Disorders
        5. Cancer
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Homecare Settings
        4. Research Institutes
        5. Others
    13. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Proteins
        2. Peptides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gastric and Digestive Disorders
        2. Bone Diseases
        3. Diabetes
        4. Hormonal Disorders
        5. Cancer
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Homecare Settings
        4. Research Institutes
        5. Others
  10. Middle East and Africa Oral Proteins And Peptides Market Size Analysis
    1. Introduction
    2. Oral Proteins And Peptides Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
      1. Linaclotide
      2. Plecanatide
      3. Calcitonin
      4. Insulin
      5. Octreotide
      6. Others
    3. Oral Proteins And Peptides Market Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
      1. Proteins
      2. Peptides
    4. Oral Proteins And Peptides Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Gastric and Digestive Disorders
      2. Bone Diseases
      3. Diabetes
      4. Hormonal Disorders
      5. Cancer
      6. Others
    5. Oral Proteins And Peptides Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Clinics
      3. Homecare Settings
      4. Research Institutes
      5. Others
    6. UAE
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Proteins
        2. Peptides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gastric and Digestive Disorders
        2. Bone Diseases
        3. Diabetes
        4. Hormonal Disorders
        5. Cancer
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Homecare Settings
        4. Research Institutes
        5. Others
    7. Turkey
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Proteins
        2. Peptides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gastric and Digestive Disorders
        2. Bone Diseases
        3. Diabetes
        4. Hormonal Disorders
        5. Cancer
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Homecare Settings
        4. Research Institutes
        5. Others
    8. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Proteins
        2. Peptides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gastric and Digestive Disorders
        2. Bone Diseases
        3. Diabetes
        4. Hormonal Disorders
        5. Cancer
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Homecare Settings
        4. Research Institutes
        5. Others
    9. South Africa
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Proteins
        2. Peptides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gastric and Digestive Disorders
        2. Bone Diseases
        3. Diabetes
        4. Hormonal Disorders
        5. Cancer
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Homecare Settings
        4. Research Institutes
        5. Others
    10. Egypt
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Proteins
        2. Peptides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gastric and Digestive Disorders
        2. Bone Diseases
        3. Diabetes
        4. Hormonal Disorders
        5. Cancer
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Homecare Settings
        4. Research Institutes
        5. Others
    11. Nigeria
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Proteins
        2. Peptides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gastric and Digestive Disorders
        2. Bone Diseases
        3. Diabetes
        4. Hormonal Disorders
        5. Cancer
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Homecare Settings
        4. Research Institutes
        5. Others
    12. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Proteins
        2. Peptides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gastric and Digestive Disorders
        2. Bone Diseases
        3. Diabetes
        4. Hormonal Disorders
        5. Cancer
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Homecare Settings
        4. Research Institutes
        5. Others
  11. LATAM Oral Proteins And Peptides Market Size Analysis
    1. Introduction
    2. Oral Proteins And Peptides Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
      1. Linaclotide
      2. Plecanatide
      3. Calcitonin
      4. Insulin
      5. Octreotide
      6. Others
    3. Oral Proteins And Peptides Market Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
      1. Proteins
      2. Peptides
    4. Oral Proteins And Peptides Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Gastric and Digestive Disorders
      2. Bone Diseases
      3. Diabetes
      4. Hormonal Disorders
      5. Cancer
      6. Others
    5. Oral Proteins And Peptides Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Clinics
      3. Homecare Settings
      4. Research Institutes
      5. Others
    6. Brazil
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Proteins
        2. Peptides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gastric and Digestive Disorders
        2. Bone Diseases
        3. Diabetes
        4. Hormonal Disorders
        5. Cancer
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Homecare Settings
        4. Research Institutes
        5. Others
    7. Mexico
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Proteins
        2. Peptides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gastric and Digestive Disorders
        2. Bone Diseases
        3. Diabetes
        4. Hormonal Disorders
        5. Cancer
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Homecare Settings
        4. Research Institutes
        5. Others
    8. Argentina
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Proteins
        2. Peptides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gastric and Digestive Disorders
        2. Bone Diseases
        3. Diabetes
        4. Hormonal Disorders
        5. Cancer
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Homecare Settings
        4. Research Institutes
        5. Others
    9. Chile
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Proteins
        2. Peptides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gastric and Digestive Disorders
        2. Bone Diseases
        3. Diabetes
        4. Hormonal Disorders
        5. Cancer
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Homecare Settings
        4. Research Institutes
        5. Others
    10. Colombia
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Proteins
        2. Peptides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gastric and Digestive Disorders
        2. Bone Diseases
        3. Diabetes
        4. Hormonal Disorders
        5. Cancer
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Homecare Settings
        4. Research Institutes
        5. Others
    11. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Proteins
        2. Peptides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gastric and Digestive Disorders
        2. Bone Diseases
        3. Diabetes
        4. Hormonal Disorders
        5. Cancer
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Homecare Settings
        4. Research Institutes
        5. Others
  12. Competitive Landscape
    1. Oral Proteins And Peptides Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Novo Nordisk A/S
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Johnson & Johnson Services Inc.
    3. Oramed Pharmaceuticals Inc.
    4. Emisphere Technologies, Inc.
    5. Rani Therapeutics
    6. Chiasma, Inc.
    7. Allergan plc
    8. Enteris BioPharma, Inc.
    9. Ipsen Pharma
    10. Biocon Limited
    11. Protagonist Therapeutics, Inc.
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports

  16. Disclaimer

We are featured on: